What happened

Anthropic, the company behind the Claude chatbot, priced its initial public offering at $83 a share on Wednesday evening, above the $70 to $78 range it set when the roadshow began on 10 November. Shares are due to start trading on the Nasdaq Global Select Market today, 19 November, under the ticker ANT, and the sale is expected to close on 20 November.

The deal was also made bigger. Anthropic's own pricing statement says the offering covers 980 million Class A shares, up from the 825 million originally marketed. Of those, 956,351,354 are being sold by the company and 23,648,646 by existing shareholders, who keep their own proceeds. Underwriters also hold a 30-day option to buy up to 147 million more shares.

The numbers

Reuters, CNBC and NPR all put the headline raise at about $81.3bn, which makes it the largest stock-market debut on record. It edges past SpaceX's listing earlier this year, which NPR and the AP put at about $75bn. Axios notes that SpaceX's figure rises to $86.25bn once its extra-share option is counted, so the comparison is closer if Anthropic's own option is exercised.

NPR calculates that the company itself keeps roughly $79.4bn of the total, before underwriting fees and expenses. On top of that, filings show Anthropic is raising $26bn through a private placement at the same $83 price. Axios names Nvidia, Google and Microsoft among the tech giants taking part in it.

The valuation depends on how you count. On a fully diluted basis, which includes options and restricted stock, Reuters and the AP put Anthropic at about $1.5 trillion. On a non-diluted basis Reuters says it is about $1.1 trillion, and Axios gives an initial market cap of $1.08 trillion. Axios adds that the most recent private round valued the company at $965bn, so the like-for-like step up is the fully diluted figure.

Why it matters beyond Wall Street

Anthropic is the first major frontier AI model developer to go public, according to Reuters. Until now, anyone wanting a stake in the companies that build the large models had to buy shares in their suppliers and partners, or wait for private funding rounds. A listed Anthropic gives the market a direct price on an AI lab for the first time, and a very public scoreboard for its rivals.

That scoreboard matters for robotics too. Models such as Anthropic's Claude family are increasingly being tested as the brains for physical machines, and capital markets decide how many of those experiments get funded. We covered the company's recent claims on robot benchmarks in our report on Fable 5.2, and those figures were the company's own.

The mood behind the deal

The pricing lands at an awkward moment. The AP says the strong pricing signals broad investor enthusiasm for AI stocks even amid uncertainty after the ouster of Nvidia's chief executive and worries about an AI bubble. Reuters' morning market note says concerns about AI profitability and debt-fuelled spending on infrastructure have dented sentiment for weeks, and that Asian equities were not basking in the afterglow on Thursday.

We have followed that wobble closely. Our earlier pieces cover the AI stocks sell-off and the doubts it raised about the listing, Jensen Huang's resignation and Nvidia's record quarter. Our earlier look at the filings is in the roadshow report.

The demand story is notable against that backdrop. NPR reports the offering was oversubscribed, and Reuters says the upsizing came after strong investor demand. Pricing above the range and adding shares are usually signs of a book that was comfortably full.

What to watch today

Pricing is not the same as trading. The Guardian reports that chief executive Dario Amodei and the other co-founders are due to ring the opening bell. How the shares behave after that will be the real test, as the AP puts it. Some pre-listing markets were pointing higher, but those are derivatives and not shares, and they do not forecast where the Nasdaq opens.

Three things are worth keeping an eye on. First, the opening price against $83, and whether it holds through the day. Second, whether underwriters use the 147 million share option, which would lift the total raised. Third, the knock-on for other AI listings and for the chip and cloud companies that sit behind the labs, including those taking part in the private placement.

What this does not tell us

A record raise is not evidence that the business is sound. The filings we covered earlier showed heavy losses and very large compute commitments, and a $1.5 trillion valuation assumes growth well beyond today's revenue. Investors who buy at or above $83 are betting on that growth. Nothing here is investment advice, and the share price could move sharply either way once trading begins.

The figures above come from the company's own statement and from the news organisations listed below. Where outlets differ slightly, for example on how much the company itself receives compared with the headline total, we have said so rather than picking one.

How to read the jargon

A few terms are doing a lot of work in the coverage. The "greenshoe" is the underwriters' option to buy extra shares at the offer price if demand is strong, which is why the final total can still grow. A "private placement" is a separate sale of shares to chosen investors rather than the public. "Fully diluted" counts every share that could exist once options and restricted stock are exercised, so it always gives a larger valuation than the simple count of shares in issue today.

For ordinary readers in the UK, the practical point is access. The shares are listed in the US, so buying them means going through a broker that offers US stocks, and currency and fees will apply. It is also worth remembering that very large first-day moves, up or down, are common in headline listings.

Keep exploring